Urinalysis is the analysis of urine to diagnose various health disorders. It may be used to screen for and/or help diagnose conditions such as urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. With the availability of advanced instruments such as automated urine analyzers and CLIA-waived urine reagent strips, the urinalysis market is attaining high growth. According to a new report from Grand View Research, Inc., the global urinalysis market is expected to achieve high growth till 2022. Major factors that are influencing the growth of this global market are - rising prevalence of target diseases, misdiagnosis, low awareness levels pertaining to urine analysis in low-income countries, high incidences of obesity coupled with hypertension, diabetes, and other chronic disorders.
Key market players mentioned in the report include:
- Roche Diagnostics
- Alere, Inc.
- Siemens Healthcare
- Bio-Rad
- ARKRAY, Inc.
- Mindray
- Sysmex
These manufacturers are constantly engaged in the development of novel diagnostic products in an attempt to ensure their sustainability and increase the penetration of their product portfolio. For instance, Roche has launched a fully automated urine testing analyzer named Cobas 6500 in June 2014, to enhance staff safety and increase the result reliability.
Key findings in the report are:
- The global urinalysis market is expected to reach over USD 2.14 billion by 2022
- Owing to a rise in the demand for automated and user-friendly urinalysis products for long-term diabetes management, diabetes is estimated to be the fastest growing application segment with a CAGR of over 10% during the forecast period.
- The instrument segment is expected to witness the fastest growth with a CAGR of over 7%. Automation of instruments with improved efficiency and reliability is expected to govern this segment's growth.
- The availability of technologically enabled point-of-care urinalysis systems, such as CLINITEK Status, is a key factor expected to reinforce the market growth.
- Owing to factors such as introduction of advanced urine analyzers by key market players in the U.S., favorable government initiatives ensuring the betterment of healthcare testing, and the high amount of healthcare spending, North America dominates the market.
End users of this market are reported to be hospitals, clinical laboratories, home healthcare and research and academics.